Unfortunately, the lack of quality control on the manufacturer's side has not only brought gloom for the loved ones who've lost their kids due to their substandard cough syrups but humiliation for our country.
Especially when we are on a mission to become self-sufficient and a prominent manufacturing hub for world-class medicines.Mustapha Bittaye, the head of health in the Gambia, verified the children's deaths from acute renal damage.
In response to the fatalities, the World Health Organization issued a medical alert, classifying four medications produced by the Haryana planted Maiden Pharmaceuticals Limited as "subpar pharmaceutical products": Promethazine Oral Solution, Makoff Baby Cough Syrup, Kofexmalin Baby Cough Syrup, and Magrip N Cold Syrup.
WHO Executive Tedros Adhanom Ghebreyesus stated, "WHO has notified a pharmaceutical product alert for four tainted medications found in The Gambia which have been potentially associated with acute renal injury and 66 children fatalities."
The Gambia has begun a door-to-door initiative to demand the urgent withdrawal of cough and cold medications produced in India, which are to blame for the fatalities of more than children of different ages in the West African nation.
The ministry of health sent a group of young people on a house-to-house effort to collect the questionable syrups while collaborating with the Gambia Red Cross Society.
In India, an investigation into tainted medications is being carried out by the federal authority and the state authority of the northern Haryana state. In addition, a top official at Maiden Pharmaceuticals revealed that the business is attempting to learn more information about the deaths of infants from its buyer in the Gambia.
"Since it suddenly surfaced this morning, we are attempting to learn more about the issue," according to one of its directors, Naresh Kumar Goyal." We're investigating everything to determine what happened with the buyer and other events. We don't have any products for sale in India."
According to reports, the business has a history of repeatedly violating quality control norms. For example, the Indian government claimed that the four cough syrups discovered to contain dangerously high amounts of ethylene glycol and diethylene glycol caused the state drug controller only authorize kidney ailments for export and sale in the Gambia.
In addition, the firm has been flagged in several Indian states well over the years for their medications breaching the standards for quality and safety.If only the previous record of this company had been seriously taken into account, they could have avoided this.
2011 saw Maiden Pharmaceuticals placed on a government blocklist in Bihar for delivering subpar medications. In 2017, a Judicial First-Class Magistrate Court in Kerala punished this corporation with a minor ransom of Rs 1,000 in response to a complaint by a Keralan Drug Inspector in 2005.
A central government drug inspector sued the Sonipat, Haryana-based firm for quality breaches under the Drugs & Cosmetics Act. At least two state governments, Kerala and Gujarat, have issued repeated warnings about the company's unlawful operations, according to the extended license, Laboratory and Legal Node (XLN) database administered by the Government of India. Naresh Goyal, the business's promoter, has not returned calls or texts.
Edited by- Devnum Nagar
Share This Post On
Leave a comment
You need to login to leave a comment. Log-in